Sign in

CIK 0001652130 · Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364785571
Phone
857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
  1. 4 Grant or award Director acquired 4,425 shares (grant or award)
  2. 4 Grant or award Director acquired 4,425 shares (grant or award)
  3. 4 Grant or award Director acquired 4,425 shares (grant or award)
  4. 4 Grant or award Director acquired 4,425 shares (grant or award)
  5. 4 Grant or award Director acquired 4,425 shares (grant or award)
  6. 4 Grant or award Director acquired 4,425 shares (grant or award)
  7. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  8. 8-K Event Regulation FD disclosure · Other events
  9. DEFA14A Proxy Proxy Materials
  10. 8-K Event Executive or director change · Regulation FD disclosure
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations
  13. DEFA14A Proxy Proxy Materials
  14. DEF 14A Proxy Proxy Statement
  15. 4 Grant or award Director acquired 10,483 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. ARS Other Annual Report to Security Holders
  18. PRE 14A Proxy Proxy Statement (Preliminary)
  19. 8-K Event Executive or director change · Regulation FD disclosure
  20. 8-K Event Executive or director change

Page 12 of 37 · 725 filings